Showing results (1-10 of 98) with videos related to
Sort By:
Pageof 10
Frontiers in Bioscience : a Journal and Virtual Library|April 18, 2003
Hepatolithiasis--epidemiology and pathogenesis updateJunichi Shoda, Naomi Tanaka, Toshiaki OsugaFrontiers in Bioscience : a Journal and Virtual Library|September 9, 2005
Molecular pathogenesis of hepatolithiasis--a type of low phospholipid-associated cholelithiasisJunichi Shoda, Yoichi Inada, Toshiaki OsugaJournal of Hepato-Biliary-Pancreatic Sciences|June 9, 2012
Biliary tract carcinoma: clinical perspectives on molecular targeting strategies for therapeutic optionsJunichi Shoda, Kazunori Ishige, Hiroaki Sugiyama, et al.Medicine and Science in Sports and Exercise|May 24, 2013
Exercise reduces inflammation and oxidative stress in obesity-related liver diseasesSechang Oh, Kiyoji Tanaka, Eiji Warabi, et al.Proteomics|February 5, 2005
Proteomic analysis of livers of patients with primary hepatolithiasisTakuji Nabetani, Yo Tabuse, Akira Tsugita, et al.Plos One|December 15, 2015
Cytoprotective Role of Nrf2 in Electrical Pulse Stimulated C2C12 MyotubeMasaki Horie, Eiji Warabi, Shoichi Komine, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 23, 2019
Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver diseaseTakashi Shida, Natsumi Oshida, Sechang Oh, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 10, 2003
Progression of autoimmune-mediated hepatic lesions in a murine graft-versus-host reaction by neutralizing IL-10Rie Unno, Yasushi Matsuzaki, Shinichi Itoh, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 18, 2003
Progression of autoimmune-mediated hepatic lesions in a murine graft-versus-host reaction by neutralizing IL-10Rie Unno, Yasushi Matsuzaki, Shinichi Itoh, et al.Metabolic Syndrome and Related Disorders|April 3, 2014
Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver diseaseSechang Oh, Kiyoji Tanaka, Takehiko Tsujimoto, et al.Pageof 10